Terms ending in 2041
Every in-force patent on Abbott Laboratories's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,947,505 | Systems and Methods for Tracking Data Lineage and Record Lifecycle Using Distributed Ledgers In force · High confidence | JPMorgan Chase Bank, N.A. | In force | High confidence | |
| US 12,278,014 | Technology to Automatically Identify the Most Relevant Health Failure Risk Factors In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 12,396,845 | Fabric Material For Medical Devices In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US D1,154,347 | Bottle In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 12,096,785 | Lipid Emulsion Nutritional Product In force · High confidence | Abbott Laboratories | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Abbott Laboratories.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.